Letters, Testimony & Comments

Pennsylvania House of Representatives Health Committee Hearing House Bill 746 September 11, 2013 Good Morning: My name is Fritz...
September 17 2013
The Honorable Rick Scott Office of the Governor State of Florida 400 S. Monroe St. Tallahassee, FL 32399-0001 Dear Governor Scott...
May 8 2013
Representative Matt Hudson Florida House of Representatives 402 South Monroe Street Tallahassee, FL 32399 Dear Representative Hudson...
February 1 2013
Biologics are complex medicines manufactured from living organisms. Unlike traditional “small molecule” drugs, biologics are...
January 24 2013
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association. BIO represents more than 1,...
January 24 2013
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association. BIO represents more than 1,...
January 24 2013
In December 2012, Virginia House Delegate John M. O'Bannon, III introduced the Interchangeable biosimilar biological products bill (H...
January 10 2013
February 22, 2012 Texas Health and Human Services Commission Attn: Stacey Johnston Policy Analyst Medicaid/Children’s Health...
March 1 2012
Economic Development and Jobs for the Michigan Bioscience Industry Michigan House and Senate Standings Committee on the Biosciences...
September 13 2011
Committee on Transportation New Hampshire State Senate Hearing on HB 374, banning corn-based ethanol as an additive to gasoline sold...
April 28 2011
Testimony of the Biotechnology Industry Organization (BIO) Hearing of the House Committee on Health, Education and Welfare April 13,...
April 13 2011
Statement Opposing S.B. 2276 The Biotechnology Industry Organization (BIO) respectfully submits the following statement in opposition...
March 23 2011
"An Act establishing procedures for sampling plants protected by patent or other intellectual property laws; requiring mediation of...
February 1 2011
Comments on the “Rule Requiring Use of Best Management Practices for Growing Crops to Minimize Cross Contamination” Dear...
December 14 2009
Testimony of the Massachusetts Biotechnology Council (MBC) and the Biotechnology Industry Organization (BIO) Hearing of the...
November 19 2009
House Bill 109-An Act Prohibiting the Use of Health Data for Marketing Purposes Senate Bill 17-An Act Relative to Data Mining Senate...
March 26 2009
House Health and Government Operations Committee March 12, 2009 House Bill 1155-Prescription Confidentiality Act BIO opposes House...
March 12 2009
The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on Senate Bill 1050. BIO is the largest trade...
March 2 2009
The Biotechnology Industry Organization (BIO) respectfully submits the following comments in opposition to Senate Bill 1049. An Act...
March 2 2009
Montana House Human Services Committee February 9, 2009 Statement of Opposition to House Bill HB394 Chair Becker and members of the...
February 9 2009
Re: Veto Request of Puerto Rico House of Representatives Bill Number 506 Dear Governor Acevedo-Vila: On behalf of the Biotechnology...
July 30 2008
Subject: Department of Health, Chapter 83, Pharmaceutical Detailers, of Title 17, Business Occupations and Professions, of the District...
July 24 2008
Dear Speaker Pelosi, Rep. Obey, Rep. Lewis, and Rep. Walsh, On behalf of the undersigned organizations, representing the life sciences...
October 25 2007
RE: Inclusion of Prescription Drugs for Minimum Credible Coverage Dear Dr. Kingsdale: On behalf of the Biotechnology Industry...
March 15 2007
HOUSE COMMITTEE ON ENERGY & ENVIRONMENTAL PROTECTION February 1, 2007 House Bill 1048 Relating to Genetically Modified Crops Chair...
February 1 2007
Dear Governor Doyle: On behalf of the Biotechnology Industry Organization (BIO) and the Wisconsin Biotechnology and Medical Device...
October 3 2005
Dear Governor Murkowski: On behalf of the Biotechnology Industry Organization (BIO), we would like to express concern about a bill...
May 11 2005
Testimony of the Biotechnology Industry Organization Submitted to the California Assembly Committee on Agriculture April 29, 2005...
April 29 2005
Testimony of the Biotechnology Industry Organization (BIO) Before the Texas House of Representatives State Affairs Committee Regarding...
April 11 2005
Testimony of the Biotechnology Industry Organization (BIO) Before the Maryland House Health and Government Operations Committee...
March 3 2005
Testimony of the Biotechnology Industry Organization (BIO) Before the Maryland Senate Education, Health and Environmental Affairs...
March 2 2005
RE: Comments regarding August 26, 2004 Meeting of California Fish and Game Commission, Agenda Item 3 Dear Mr. Kellogg: On behalf of...
August 25 2004
On behalf of the Biotechnology Industry Organization (BIO), please accept this letter in support of Senate Bill 74, a bill that would...
May 26 2004
Please accept this statement on  behalf of the Biotechnology Industry Organization (BIO) and its member companies regarding HCR270/...
April 7 2004
Testimony on the Biotechnology Industry Organization Submitted to the New York State Senate Committee on Environmental Conservation...
March 19 2004
MEMORANDUM IN OPPOSITION OF LEGISLATION S. 6537, Senator Carl Marcellino Prohibits the sale of transgenic aquatic animals On behalf of...
March 10 2004
On behalf of the Biotechnology Industry Organization and its more than 1,000 member companies, please accept this testimony in opposition...
March 3 2004
The Biotechnology Industry Organization (BIO) opposes mandatory, generalized labeling requirements for biotech foods like those proposed...
February 27 2004
Testimony of the Biotechnology Industry Organization Submitted to the House Economic Development and Business Concerns Committee...
February 12 2004
RE: Decision not to exempt transgenic ornamental fish from the resticted species list in Section 671, Title 14 California Code of...
February 4 2004
Dear Governor Davis: The below signed organizations are opposed to SB 245 (Sher) and respectfully request your veto of the bill. This...
August 27 2003
RE: Concerns with Senate Bill 2863 Dear Governor Patrick, On behalf of the more than 1,200 members of the Biotechnology Industry...
Testimony of the Biotechnology Industry Organization to the Oregon Senate Environment & Land Use Committee Regarding Senate Bill...
Dear Mr. Chairman: On behalf of the Biotechnology Industry Organization (BIO), I am writing to encourage you to consider the very...
January 21 2014
BIO's Senior Policy Consultant, Peter Pellerito, testified before the Michigan Legislature's Bioscience Caucus on economic development initiatives that support the growth of the bioscience industry.
September 17 2013
Fritz Bittenbender, Senior Vice President of External Affairs, delivered testimony supporting a pathway for patients to access lower cost interchangeable biological products.
May 8 2013
BIO  urges Florida Governor Scott to sign House Bill 365 – a bill related to the substitution of biologic and biosimilar medicines – which recently passed out of the Legislature.
February 1 2013
BIO supports passage of Florida House Bill 365, which provides requirements for pharmacist to dispense substitute biological products that are determined to be interchangeable for prescribed biological product.
January 24 2013
To ensure transparency and communication between patients and their treatment teams, BIO believes that certain safeguards should guide substitution policies for interchangeable biologics under state law as well.
May 16 2014
BIO and Delaware Bio call upon Governor Markell to sign critical legislation to create a pathway for the substitution of interchangeable biologic medicines.
April 10 2014
BIO and Delaware Bio commend the Delaware State Senate for unanimously passing legislation yesterday designed to create a pathway for the substitution of interchangeable biologic medicines. 
March 25 2014
The Biotechnology Industry Organization (BIO) and the Indiana Health Industry Forum (IHIF) commend Indiana Governor Mike Pence for signing legislation today designed to create a pathway for the substitution of interchangeable biologic medicines.
January 22 2014
BIO and WBBA commend the Washington State House and Senate for continuing to advance legislation designed to create a pathway for the substitution of interchangeable biologic medicines.
November 13 2013
The Pennsylvania Senate Public Health and Welfare Committee approved Senate Bill 405, which would require a pharmacist to notify the patient and, within 72 hours, the patient’s physician of any biologic product substitution.